新城疫病毒样颗粒研究进展

doi:10.11843/j.issn.0366-6964.2014.05.002

Abstract

Abstract:

Virus-like particles (VLPs) refers to the virus structural protein self assembling into particles without virus gneome by using heterologous host system.It can’t copy and does not have the infection ability.VLPs combine many of the advantages，such as，well-defined geometry，safety，high stability，inducing strong humoral and cellular immune responses，applicability as vectors for the presentation of foreign antigens and amenable to fulfil the Differentiating Infected from Vaccinated Animals (DIVA).On behalf of above advantages，over the last three decades，VLPs have evolved to become a widely accepted new technology in the field of vaccinology.Here，in order to provide reference to the research of Newcastle disease VLPs，we review the current status of Newcastle disease VLPs to provid a guidelines for us to study the Newcastle disease VLPs in the future.

CLC Number:

S852.659.5

GE Sheng-qiang， ZHAO Ming，WU Xiao-dong，WANG Jing-jing，LIU Hua-lei，BAO Jing-yue，WANG Zhi-liang. Progress of Newcastle Disease Virus-like Particles[J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2014, 45(5): 686-691.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://www.xmsyxb.com/EN/10.11843/j.issn.0366-6964.2014.05.002

https://www.xmsyxb.com/EN/Y2014/V45/I5/686

References

［1］PANDEY A，SINGH N，SAMBHARA S,et al.Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses［J］.Hum Vaccin，2010，6(2):178-188.
［2］ZHOU S，LIU R，ZHAO X，et al.Viral proteomics：the emerging cutting-edge of virus research［J］. Sci China Life Sci，2011，54(6):502-512.
［3］FREUNDLICH M M.Origin of the Electron Microscope［J］.Science，1963，142(3589):185-188.
［4］PORTER K R，THOMPSON H P.A particulate body associated with epithelial cells cultured from mammary carcinomas of mice of a milk-factor strain［J］.J Eep Med，1948，88(1):15-24.
［5］戈胜强，王志亮.禽流感病毒样颗粒研究进展［J］.病毒学报，2013，29(2):224-232.
［6］KENDAL A P，GALPHIN J C，PALMER E L.Replication of influenza virus at elevated temperatures：production of virus-like particles with reduced matrix protein content［J］.Virology，1977，76(1):186-195.
［7］NEUMANN H，SCHWASS V，ECKERSKORN C，et al.Identification and characterization of the genes encoding three structural proteins of the Thermoproteus tenax virus TTV1［J］.Mol Gen Genet，1989，217(1):105-110.
［8］BURRELL C J，MACKAY P，GREENAWAY P J，et al.Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322［J］.Nature，1979，279(5708):43-47.
［9］COHEN B J，RICHMOND J E.Electron microscopy of hepatitis B core antigen synthesized in E.coli［J］.Nature，1982，296(5858):677-679.
［10］SMITH G E，SUMMERS M D，FRASER M J.Production of human beta interferon in insect cells infected with a baculovirus expression vector［J］.Mol Cell Biol，1983，3(12):2156-2165.
［11］ZELTINS A.Construction and characterization of virus-like particles：a review［J］.Mol Biotechnol，2013，53(1):92-107.
［12］ROY P.Genetically engineered particulate virus-like structures and their use as vaccine delivery systems［J］.Intervirology，1996，39(1-2):62-71.
［13］GÓMEZ-PUERTAS P，ALBO C，PÉREZ-PASTRANA E，et al.Influenza virus matrix protein is the major driving force in virus budding［J］.J Virol，2000，74(24):11538-11547.
［14］LI T C，ZHANG J，SHINZAWA H，et al.Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus［J］.J Med Virol，2000，62(3):327-333.
［15］COURSAGET P.Serology for human papillomavirus［J］.Salud Publica Mex，2003，45(Sup3):S361-366.
［16］TAKAMURA S，NIIKURA M，LI T C，et al.DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration［J］.Gene Ther，2004，11(7):628-635.
［17］CHACKERIAN B.Virus-like particles：flexible platforms for vaccine development［J］.Expert Rev Vaccines，2007，6(3):381-390.
［18］JENNINGS G T，BACHMANN M F.The coming of age of virus-like particle vaccines［J］.Biol Chem，2008，389(5):521-536.
［19］ROY P，NOAD R.Virus-like particles as a vaccine delivery system：myths and facts［J］.Hum Vaccin，2008，4(1):5-12.
［20］PLUMMER E M，MANCHESTER M.Viral nanoparticles and virus-like particles：platforms for contemporary vaccine design［J］.Wires Nanomed Nanobi，2010，3(2):174-196.
［21］ROLDÃO A，MELLADO M C，CASTILHO L R，et al.Virus-like particles in vaccine development［J］.Expert Rev Vaccin，2010，9(10):1149-1176.
［22］MICHEL M L，TIOLLAIS P.Hepatitis B vaccines：protective efficacy and therapeutic potential［J］.Pathol Biol (Paris)，2010，58(4):288-295.
［23］NOAD R，ROY P.Virus-like particles as immunogens［J］.Trends Microbiol，2003，11(9):438-444.
［24］FAUSCH S C，DA SILVA D M，EIBEN G L，et al.HPV protein/peptide vaccines：from animal models to clinical trials［J］. Front Biosci，2003，8:s81-91.
［25］STANLEY M A.Progress in prophylactic and therapeutic vaccines for human papillomavirus infection［J］.Expert Rev Vaccin，2003，2(3):381-389.
［26］HARPER D M，FRANCO E L，WHEELER C，et al.Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women：a randomised controlled trial［J］. Lancet，2004，364(9447):1757-1765.
［27］KEIM B.Controversy over cervical cancer vaccine spurs safety surveillance［J］.Nat Med，2007，13(4):392-393.
［28］CORONEL E C，MURTI K G，TAKIMOTO T，et al.Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures［J］.J Virol，1999，73(8):7035-7038.
［29］CIANCANELLI M J，BASLER C F.Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization［J］.J Virol，2006，80(24):12070-12078.
［30］PATCH J R，CRAMERI G，WANG L F，et al.Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein［J］.Virol J，2007，4:1.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781425/pdf/1743-422X-4-1.pdf.
［31］TAKIMOTO T，MURTI K G，BOUSSE T，et al.Role of matrix and fusion proteins in budding of Sendai virus［J］. J Virol，2001，75(23):11384-11391.
［32］SCHMITT A P，LESER G P，WANING D L，et al.Requirements for budding of paramyxovirus simian virus 5 virus-like particles［J］.J Virol，2002，76(8):3952-3964.
［33］LIU F，WU X，LI L，et al.Use of baculovirus expression system for generation of virus-like particles：successes and challenges［J］.Protein Expr Purif，2013，90(2)：104-116.
［34］KANG S M，SONG J M，QUAN F S，et al.Influenza vaccines based on virus-like particles［J］.Virus Res，2009，143(2):140-146.
［35］WANG X J，GU K，XIONG Q Y，et al.A novel virus-like particle based on hepatitis B core antigen and substrate-binding domain of bacterial molecular chaperone DnaK［J］.Vaccine，2009，27(52):7377-7384.
［36］JIANG Z，TONG G，CAI B，et al.Purification and immunogenicity study of human papillomavirus 58 virus-like particles expressed in Pichia pastoris［J］.Protein Expr Purif，2011，80(2):203-210.
［37］MORRISON T G，PANTUA H D.Virus-like particles as vaccines for paramyxovirus：USA，WO2007019247 A2 ［P］.
［38］MAHMOOD K，SMITH G，PUSHKO P.Chimeric Newcastledisease virus VLPs：USA，WO 2008103819 A2 ［P］.
［39］PANTUA H D，MCGINNES L W，PEEPLES M E，et al.Requirements for the assembly and release of Newcastle disease virus-like particles［J］.J Virol，2006，80(22):11062-11073.
［40］MCGINNES L W，PANTUA H，LALIBERTE J P，et al.Assembly and biological and immunological properties of Newcastle disease virus-like particles［J］.J Virol，2010，84(9):4513-4523.
［41］冷勇，宋振辉，卿家超，等.猪传染性胃肠炎病毒M、sM基因重组杆状病毒的构建及病毒样颗粒的组装［J］.畜牧兽医学报，2013，44（9）：1432-1437.
［42］闻晓波.新城疫病毒样颗粒的构建及其出芽机制的研究［D］.北京：中国农业科学院，2006.
［43］吴芬芳，闫丽辉，曹殿军，等.新城疫病毒样颗粒(ND—VLPs)免疫效力的研究［J］.中国预防兽医学报，2008，30(1):42-46，63.
［44］MURAWSKI M R，MCGINNES L W，FINBERG R W，et al.Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice，with no evidence of immunopathology［J］.J Virol，2010，84(2):1110-1123.
［45］MCGINNES L W，GRAVEL K A，FINBERG R W，et al.Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins［J］.J Virol，2011，85(1):366-377.
［46］SHEN H，XUE C，LV L，et al.Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease［J］.Virus Res，2013，178(2):430-436.
［47］NAGY E，HUBER P，KRELL P J，et al.Synthesis of Newcastle disease virus (NDV)-like envelopes in insect cells infected with a recombinant baculovirus expressing the haemagglutinin-neuraminidase of NDV［J］.J Gen Virol，1991，72(Pt3):753-756.
［48］ONG H K，ALI A M，OMAR A R，et al.Cloning and expression of the HN， gene from the velogenic viscerotropic Newcastle disease virus strain AF2240 in Sf9 insect cells［J］.Cytotechnology，2000，32(3):243-251.
［49］李太元，金宁一，丁壮，等.新城疫病毒F₄₈E₈株HN基因在杆状病毒系统中表达［J］.中国生物制品学杂志，2002，15(6):334-336.
［50］SEAL B S，KING D J，SELLERS H S.The avian response to Newcastle disease virus［J］.Dev Comp Immunol，2000，24(2-3):257-268.
［51］TAKIMOTO T，PORTNER A.Molecular mechanism of paramyxovirus budding［J］.Virus Res，2004，106(2):133-145.
［52］SANDERSON C M，WU H H，NAYAK D P.Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo［J］.J Virol，1994，68(1):69-76.
［53］ALI A，NAYAK D P.Assembly of Sendai virus：M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein［J］.Virology，2000，276(2):289-303.
［54］MORRISON T G.Newcastle disease virus-like particles as a platform for the development of vaccines for human and agricultural pathogens［J］.Future Virol，2010，5(5):545-554.
［55］BRIGHT R A，CARTER D M，CREVAR C J，et al.Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle［J］.PLoS One，2008，3(1)：e1501.

[1]	MENG Lingzhai, CHEN Chunli, YU Mengmeng, WANG Zhanxin, WANG Suyan, LIU Peng, HE Tana, GUO Ru, CHEN Yuntong, LIU Changjun, QI Xiaole, WU Zhiqiang, GAO Yulong. Pathogenicity of Avian Metapneumovirus Subtype B on Yellow Feather Broilers and Evaluation on Immune Effect of Inactivated Vaccine [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(12): 5154-5161.
[2]	JIANG Shengqiang, HU Jing, CHEN Hongying. Expression Analysis of CircRNAs in A549 Cells Infected with H1N1 Influenza A Virus [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(11): 4724-4734.
[3]	ZHANG Ao, TAN Bin, LIU Kexin, LIU Jiali, ZHANG Shuqin. Genomic Characterization Analysis of a H1N1 Subtype Swine Influenza Virus [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(11): 4866-4871.
[4]	HE Chenxiang, GAO Shandian, TIAN Zhancheng, DU Junzheng, WANG Jinming, GUAN Guiquan, YIN Hong. Development of a Differential Diagnostic ELISA Based on G_NS Protein to Distinguish BEFV Infected and Vaccinated Cattle [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(10): 4320-4326.
[5]	CHANG Yiming, TANG Cheng, YUE Hua. Molecular Epidemiological Investigation of Bovine Respiratory Syncytial Virus in Yaks [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(5): 2030-2041.
[6]	FANG Yuan, HOU Qiaodi, XIANG Chaohui, ZHAO Hongyi, QI Xuefeng. Regulatory Effects of IFITM3 on Proliferation of Peste des Petits Ruminants Virus (PPRV) in Goat Endometrial Epithelial Cells [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(5): 2200-2207.
[7]	LI Shun, LI Guizhen, YUAN Yaoxian, LI Kangjian, MA Chunquan, LI Shoujun, HUANG Liangzong, MA Jun. Effect of the Length of PA-X Gene on Replication and Pathogenicity of H3N2 Canine Influenza Virus [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(1): 272-280.
[8]	CUI Mingxian, WANG Xingbo, HUANG Yanming, BIAN Xiyi, FENG Mengke, YAN Yan, DONG Weiren, ZHOU Jiyong. Genetic Characterization and Evolution of Three Strains of H3N2 Avian Influenza Viruses [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(11): 4116-4122.
[9]	YU Mengmeng, BAO Yuanling, WANG Suyan, XIN Ziqi, LIU Peng, FENG Xiaoyan, MENG Lingzhai, GUO Ru, ZHANG Yanping, LIU Changjun, QI Xiaole, LI Junping, WANG Xiaomei, GAO Yulong. Isolation, Identification and Pathogenicity of Subtype B Avian Metapneumovirus [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(10): 3540-3549.
[10]	ZHOU Yong, LI Zhixin, LU Hongwei, SUN Yan, LI Tian, DU Fanshu, PU Juan. Surveillance and Outbreak Analysis of H5 and H7N9 Subtypes of Highly Pathogenic Avian Influenza in China [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(9): 3093-3106.
[11]	PAN Chunrong, DENG Ruixue, HU Linjie, ZHU Xueliang, SUN Yuefeng, WANG Guirong, MENG Xuelian. Effect of Histone Deacetylase Inhibitors on Peste Des Petits Ruminants Virus Replication [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(7): 2307-2316.
[12]	CHEN Zixuan, ZHANG Nan, HU Qun, QUAN Keji, QIN Tao, CHEN Sujuan, PENG Daxin, LIU Xiufan. Mutation Analysis of Antigen Sites 145 and 153 on Hemagglutinin of H9N2 Avian Influenza Virus in China [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(4): 1165-1172.
[13]	DUAN Zhiqiang, XIE Lingling, CHEN Jiaqi, TANG Hong, WANG Yanbi, ZHAO Caiqin, ZHAO Jiafu. Research Progress on the Interactions of Newcastle Disease Virus M Protein with Host Proteins [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(1): 32-42.
[14]	YAN Yayao, GU Min, LIU Xiufan. Advance in the Influence of Amino Acid Variation in HA Protein on the Biological Properties of H7N9 Subtype Influenza Virus [J]. Acta Veterinaria et Zootechnica Sinica, 2021, 52(8): 2093-2106.
[15]	JIANG Mei, CHEN Wu, ZHAI Junqiong, BU Wandi, XIE Yilun, LIU Canbin, SHAN Fen, LUO Manlin. Cloning and Sequence Analysis of H and F Genes of Canine Distemper Virus Strain from Red Panda [J]. Acta Veterinaria et Zootechnica Sinica, 2021, 52(6): 1670-1676.

Progress of Newcastle Disease Virus-like Particles

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments